Angle PLC Announces Identifying Therapeutic Targets in TNBC Patients

PARSORTIX SHOWS POTENTIAL FOR IDENTIFYING THERAPEUTIC TARGETS IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCERParsortix system harvests intact CTCs for whole genome sequencing identifying multiple actionable targetsBoth tumour and CTC samples after …